Neuroprotective Effects of GV1001 in Animal Stroke Model and Neural Cells Subject to Oxygen-Glucose Deprivation/Reperfusion Injury
Background and Purpose Previous studies have revealed the diverse neuroprotective effects of GV1001. In this study, we investigated the effects of GV1001 on focal cerebral ischemia-reperfusion injury (IRI) in rats and oxygen-glucose deprivation/reoxygenation (OGD/R)-induced injury in neural stem cel...
Main Authors: | Hyuk Sung Kwon, Ye Eun Kim, Hyun-Hee Park, Jeong-Woo Son, Hojin Choi, Young Joo Lee, Hyun Young Kim, Kyu-Yong Lee, Seong-Ho Koh |
---|---|
Format: | Article |
Language: | English |
Published: |
Korean Stroke Society
2021-09-01
|
Series: | Journal of Stroke |
Subjects: | |
Online Access: | http://www.j-stroke.org/upload/pdf/jos-2021-00626.pdf |
Similar Items
-
Efficacy and safety of GV1001 in patients with moderate-to-severe Alzheimer’s disease already receiving donepezil: a phase 2 randomized, double-blind, placebo-controlled, multicenter clinical trial
by: Seong-Ho Koh, et al.
Published: (2021-03-01) -
Novel Peptide Vaccine GV1001 Rescues Hearing in Kanamycin/Furosemide-Treated Mice
by: Shin Hye Kim, et al.
Published: (2018-01-01) -
Outcomes of Peptide Vaccine GV1001 Treatment in a Murine Model of Acute Noise-Induced Hearing Loss
by: Sang-Yeon Lee, et al.
Published: (2020-01-01) -
The Telomerase-Derived Anticancer Peptide Vaccine GV1001 as an Extracellular Heat Shock Protein-Mediated Cell-Penetrating Peptide
by: Hong Kim, et al.
Published: (2016-12-01) -
The Effect of HK-1001 Pharmacopuncture on Hyperlipidemia Induced Rats
by: Hong Kwon-Eui, et al.
Published: (2008-06-01)